Former Scientific advisory board members
Affiliation: Faculté de médecine de l´Université Paris-Diderot Country: France
I obtained my md in 1976 ( medical school of tours university (tours, france) and my ph. d. in microbiology in 1986 at the pharmacy school of university of paris 11 (chatenay-malabry, france). i am board certified in paediatrics, tropical medicine and microbiology. i have been further trained in epidemiology at the cdc (atlanta, ga) and have been a research fellow at suny (brooklyn, ny). from 1979 to 1996 i worked as clinical microbiologist at institut gustave-roussy, the major french cancer research and treatment centre. i was appointed professor of microbiology at the pharmacy school of university paris 11 (chatenay-malabry) from 1988 to 1996. since 1996 i am full professor of microbiology at university of paris7 medical school and head of the bacteriology laboratory of bichat-claude bernard university hospital, a major referral centre in infectious diseases in the paris area. the laboratory has hosted the french national reference center for bacterial resistance in commensal flora from 2004 to 2012. i serve as expert -witness at the national highest court of appeal, and am a member of the french scientific council for defence and have been a member of the scientific council for national defence from 2002 to 2012. i am a member of the who/agisar group since 2008. My research focuses on the role of commensal microbiota in the evolution of bacterial resistance to antibiotics and on how these microbiota cause nosocomial and community-acquired infections. I am author or co-author of more than 130 pubmed publications and i published a book for the general public in collaboration with the anthropologist michel tibon-cornillot (le triomphe des bactéries : la fin des antibiotiques? [the triumph of bacteria : the end of antibiotics ?] maxmilo editions paris 2007).I am inventor of several patents, some of which serve as scientific basis for a biotech company (davolterra) created under the hospices of the french law for innovation and research and developing anti bacterial resistance products currently in pre-clinical stage.
Affiliation: UMC Utrecht Country: Nederlands
Marc Bonten (1964) studied Medicine at the University of Maastricht (1991), where he also received his PhD in 1994. In 2003 he was appointed professor of molecular epidemiology of infectious diseases. He is head of the department of Medical Microbiology (since 2008) and of the research theme Epidemiology of Infectious Diseases at the Julius Center for Health Sciences and Primary Care, both at the University Medical Center Utrecht.
Affiliation: Harvard University, Boston Country: USA Yehuda Carmeli, MD, MPH, professor of medicine, Tel Aviv University, is the Head of the Israeli National Center for Antibiotic Resistance, and the chief of the Division of Epidemiology at the Tel Aviv Medical Center, in Tel Aviv, Israel. He is also on the research staff at the Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Dr. Carmeli received his MD degree from Ben Gurion University, Israel and his MPH degree at Harvard School of Public Health. He served his residency at Hadassah Medical Center, Hebrew University, Jerusalem, and then served as a fellow in Medicine at Massachusetts General Hospital, Boston. Dr. Carmeli completed his fellowship in Infectious Diseases at Beth Israel Deaconess Medical Center, Boston, MA. His primary research interest is the epidemiology of resistance to antibiotics. Dr. Carmeli is the author of over 200 research articles, the recipient of multiple research grants and awards, and member of editorial board of major journals in the fields of Infectious Diseases and antibiotic research.
Affiliation: IRYCIS, Madrid Country: Spain Fernando Baquero was born in Madrid in 1941. He graduated in Medicine and Surgery in the Complutensis University in Madrid (1965), and received his Ph.D. in Medical Microbiology (1973) from the Autonomous University of Madrid. He was trained in clinical microbiology at the National Hospital for Infectious Diseases en Madrid, and later at Max von Pettenkofer Institute in Munich (1970), the Pasteur Institute in Paris (1973-74), and the Department of Biology at Emory University (1995). He founded and directed the Laboratory of Microbiology at La Paz University Hospital in Madrid, and later the Department of Microbiology at the Ramón y Cajal University Hospital (1977-2008); from 2008 to date, he is Research Professor in Microbial Evolution and Scientific Director of the Ramón y Cajal Health Research Institute (IRYCIS). He is Senior Scientist in Evolutionary Biology at the Center for Astrobiology (CAB, INTA-NASA associated) of the Spanish Research Council. He served as President of the Spanish Society of Microbiology, and Scientific Secretary of the Spanish Society for Chemotherapy. Founder and First President of the Spanish Programme for Training and Accreditation in the Specialty of Medical Microbiology and Parasitology. Founder member of APUA (Alliance for the Prudent Use of Antibiotics), he also served as Member of the ICAAC Programme Committee, Member of EARSS Scientific Committee, President of the ESCMID Group for Surveillance if Antimicrobial Resistance, and has been President of the European Congress for Clinical Microbiology and Infectious Diseases; currently Member of the Scientific Advisory Board of the EC Joint Programming Initiative on Antimicrobial Resistance. He received several international honors and awards, including the Excellence Awards of the American ASM-ICAAC, Award of Excellence of European Society for Clinical Microbiology and Infectious Diseases, Garrod Medal of the British Society for Antimicrobial Chemotherapy, Descartes Award of the EU Commission for International Collaborative Research, Excellence Award of the Spanish Society of Microbiology, Lilly Foundation Award to Distinguished Scientific Carrier, and Honor Member of the Spanish Society for Evolutionary Biology. He is Member of the American Academy of Microbiology, the European Academy for Microbiology, the European Academy for Clinical Microbiology and Infectious Diseases, and the Iberoamerican Academy for Evolutionary Biology. His research interests focus on the biochemistry, genetics, population biology, epidemiology, ecology, and evolutionary biology of antibiotic resistance and virulence, and particularly on the multi-level processes influencing selection of resistant microbes, and the possibilities of applying control interventions and therapies. On these and related topics, he published more than 450 full papers in peer-reviewed scientific journals and he is included in the ISI-WOK list of most quoted scientists of the world in the field of Microbiology. As side-interests, he has also published in the fields of philosophy of science, particularly in epistemology of complex biological systems.
Affiliation: Hôpitaux Universitaires de Genève Country: Switzerland Stephan Harbarth, MD, MS, is an associate professor and hospital epidemiologist at Geneva University Hospitals in Geneva, Switzerland. He also serves as senior attending physician in geriatric and general infectious diseases. Dr Harbarth earned his medical degree from Ludwig-Maximilians-University in Munich, Germany, and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division and Infection Control Program in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Cambridge, Massachusetts. He is board certified in infectious diseases. Dr Harbarth’s work has garnered several awards, including the Interscience Conference on Antimicrobial Agents and Chemotherapy Young Investigator Award from the American Society for Microbiology in 2003, the Young Investigator Award from the European Society of Clinical Microbiology and Infectious Diseases in 2006, the Swiss Society for Infectious Diseases Award for epidemiological research in 2008, and the Society of Healthcare Epidemiology of America Investigator Award in 2011.A prolific author, Dr Harbarth has written or coauthored more than 200 scientific publications and is co-editor of several peer-reviewed journals. He is member of many international societies, working groups, advisory boards and tasks forces, including WHO and ECDC.
Affiliation: Rigshospitalet Country: Denmark
Niels Frimodt-Møller (1949) graduated as MD in 1975 and specialized in clinical microbiology in 1986. His medical doctoral thesis was defended in 1988. He is an adjunct professor in clinical microbiology at Aarhus University, Denmark, and works as a senior consultant at the dept. of clinical microbiology, Hvidovre Hospital in Copenhagen. His research activities have focused on antibiotics in vitro and in vivo, both with experimental animal models and clinical studies. In the later years his interest has been focused on antibiotic resistance issues, both studying resistance mechanisms and the effect of antibiotics on resistant bacteria in vivo. He has collaborated on a number of EU FP-research programmes. The research has been published in over 300 peer reviewed papers and more than 400 congress abstracts, posters and oral presentations. He has supervised more than 20 doctoral theses or PhD´s, and he has been external reviewer of more than 30 PhDs in Denmark, Norway, Sweden and Lithuania. He has been involved also in monitoring antibiotic resistance and antibiotic consumption both in Denmark and in Europe. He was a cofounder of the Danish monitoring system, DANMAP, and has represented Denmark in various antibiotic resistance programmes and advisory groups in the EU, ECDC and ESCMID. He is a present board member at the Danish National Research Foundation, the Danish National Antibiotic Board under the Ministry of Health and several other funding and advisory boards.
Affiliation: RIVM, Bilthoven Country: Netherlands
Hajo Grundmann, born in 1955, studied Sinology, Nursing and Human Medicine at the Universities of Bochum and Freiburg,Germany. He specialised in Clinical Tropical Medicine, Medical Microbiology and Hygiene & Environmental Medicine and received his PhD at the University of Freiburg, Germany and an MSc in Epidemiology of Communicable Diseases at the London School of Hygiene. He worked clinically as a medical doctor at university hospitals inFreiburg,Berlin, and Nottingham and carried out extensive field studies in Taiwan,Venezuela and Tanzania. For eight years, he was the Project Leader of the European Antimicrobial Resistance Surveillance System (EARSS) funded by the European Commission and the Dutch Ministry of Health at the Dutch National Institute for Public Health and the Environment (RIVM) were he is still in charge of the Antimicrobial Resistance and Health Care Associated Infections Programme. Currently, he is the Chair for Infectious Diseases Epidemiology at the University of Groningen where he also holds his clinical appointment. He is also Special Professor at the University of Nottingham, UK and Co-Lead for the 3rd Challenge on Patient Safety of WHO’s Global Alliance on Patient Safety. He is scientific advisor to ReAct –Action on antibiotic resistance. His major research interests are the molecular evolution, epidemiology, population dynamics and health impact of emerging antimicrobial resistance and health care associated infections. –Address: University Medical CentreGroningen, Rijksuniversiteit Groningen, Hanzeplein 1, 9700 RBGroningen, TheNetherlands.
Affiliation: University of Antwerp Country: Netherlands
Herman Goossens was born in 1957. He graduated as a Medical Doctor (1982) and Clinical Microbiologist (1988), and received his Ph.D. in Medical Microbiology (1990) from the Free University of Brussels. He received research fellowships of the University of Geneva (1985-86), the University of Tokyo (1987), and the University of Utrecht (1988). He is a professor of Medical Microbiology at the University of Antwerp in Belgium since 1992 and founded the research Laboratory of Medical Microbiology at the University of Antwerp in 1994. He is the director of the Laboratory of Clinical Pathology of the University Hospital Antwerp since 1998. He was also a professor of Medical Microbiology at the University of Leiden in the Netherlands between 2000 and 2008. Herman Goossens received several honours and awards, including the American APUA (Alliance for the Prudent Use of Antibiotics) award in 2006. He was a Fellow of the British Council in 1987 and 1988. Herman Goossens published more than 400 full papers in peer-reviewed scientific journals and he published more than 25 chapters in textbooks. He is the founder and Vice-Chair of the Belgian Antibiotic Policy Co-ordination Committee (BAPCOC) and he founded the network of Belgian Centres for Molecular Diagnostics (CMD), both by Royal Decree. He chaired the WHO Conference on the Use of Quinolones in Food Animals and Potential Impact on Human Health in Geneva (1998). Herman Goossens was a member of the ICAAC Program Committee (2001 – 2005) and of the ECCMID Programme Committee (2005 – 2008). He coordinates several European projects funded by DG Research, DG SANCO, IMI and ECDC, such as the European Surveillance of Antibiotic Consumption (ESAC) project, Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE) and Development of RApid Point-of-care test Platforms for Infectious Diseases (RAPP-ID). Herman Goossens was the organiser of the European Conference on Antibiotic Use in 2001 on behalf of the Belgian EU Presidency, of the International Workshop on Educational Campaigns regarding antibiotic resistance in 2004, of the European Workshop on indicators for quality prescribing in primary care in 2005, and of the European Conference on Health Care Associated Infections and Antibiotic Use in 2010 on behalf of the Belgian EU Presidency. He is a member of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (WHO-AGISAR). He is the initiator of the annual European Antibiotic Resistance Day (EAAD) and chairs the Technical Advisory Committee at ECDC for EAAD. Herman Goossens was elected chair of the Scientific Advisory Board of the Joint Programming Initiative on Antimicrobial Resistance. His is/was member of the editorial board of several journals, including Journal of Antimicrobial Chemotherapy, Lancet Infectious Diseases, Clinical Microbiology & Infection and Eurosurveillance. Herman Goossens received the Methusalem award of the Flemish government in 2008 for a period of 7 years. His main fields of research are antibiotic use and resistance, respiratory tract infections (mainly VAP), developing rapid and point-of-care diagnostic tests, and biofilms. With his translational research, he seeks to enhance the standard of healthcare quality, public health and professional standards for the good of the public in large. He is a popular resource person and opinion leader, much sought after by local and international media for views on matters related to public health and infectious diseases.
Birgitta Henriques Normark
Affiliation: Karolinska Institutet, Stockholm Country: Sweden
Birgitta Henriques Normark is professor in Clinical microbiology at Karolinska Institutet and Karolinska University hospital, as well as head physician at the Swedish Institute for Communicable Diseases (SMI). She has been employed by SMI since more than 20 years and has acted as Department head and Section head. She received a 5 year research position (50%) in Clinical experimental research from the Royal Academy of Sciences in Sweden (KVA) year 2005. In 2008 she got a Research position from the Swedish Research Council 50% in Clinical bacteriology and in 2008 a Strategic Professor position at the Karolinska Institutet. Her research focuses on epidemiology, antibiotic resistance and host-microbe interactions in bacterial infections with special focus on pneumococcal epidemicity, molecular epidemiology, and mechanisms of invasive disease, innate immunity and host-microbe interactions determining disease outcome. The research has been published in 117 publications of which 89 are original peer reviewed articles. She has been the main supervisor of 12 PhD thesis as well as co-supervisor to 5 thesis. She has been invited speaker/chair at more than 70 international/ national meetings and is ad hoc reviewer for several international peer-reviewed journals. She is an evaluator of grant applications sent to several organizations worldwide and has a large network in both academia and industry and has participated/participate in several EU networks/projects and was the Coordinator of the EU network PREVIS within the 6th framework. She is also a board member of the Swedish Research Council, Medicine and Health.
Affiliation: University of Tromsø Country: Norway
Arnfinn Sundsfjord (1958) graduated as MD (1983) and in clinical microbiology (1991), received his PhD (1994), and was appointed professor in microbiology (2001) at the University of Tromsø/Unversity Hospital of North-Norway. He has spent sabbatical leaves in several European research institutions including Institute Pasteur, Paris (2000-1). He established and has chaired the National Reference Centre for Detection of Antimicrobial Resistance since 2001. He co-/chaired the National Antimicrobial Susceptibility Testing Committee (1998-2012). His research activities have targeted our understanding of mechanisms in transmission and persistence of antimicrobial resistance determinants in animals and humans, the development and evaluation of pheno- and genotypic methods for detection of antimicrobial resistance and development of new antimicrobial drugs.
Affiliation: Cardiff University Country: UK
Timothy Walsh is currently Professor of Medical Microbiology and Antibiotic Resistance at Cardiff University, Cardiff, Wales, and leads an active research in antibiotic resistance. Previously, he was a Reader in Medical Microbiology at the University of Bristol following several postdoctoral research positions in London, UK. After obtaining a BSc in Applied Laboratory Science and a Post Graduate Diploma of Immunology/Microbiology at the University of Tasmania in Australia, Prof. Walsh earned his PhD in Molecular Microbiology at the University of Bristol. He is in the process of obtaining his MRCPath (London) and DSc (Australia). Prof. Walsh is a member of the Australian Society of Microbiology, Society for General Microbiology (UK), British Society of Antimicrobial Chemotherapy, American Society of Microbiology and European Society of Clinical Microbiology and Infectious Diseases. Prof. Walsh’s research is focused on unusual mechanisms of antimicrobial resistance and how they are mobilized into the clinical sector and spread once established. He has published and presented over 400 papers, in particular on the characterization of β-lactamases within Gram-negative bacteria. His interests include designing and evaluating new antimicrobials as well as blending molecular and clinical epidemiology in large scale studies in developing countries. His research has been funded by the Wellcome Trust, European Union, British Society of Antimicrobial Chemotherapy, BBSRC, Merck etc. He is advisory on many EC steering groups and the WHO, and is a consultant to the Chinese CDC.
Affiliation: University of Nottingham Country UK
Paul Williams is currently Professor of Molecular Microbiology in the Faculty of Medicine and Health Sciences at the University of Nottingham U.K. He graduated in pharmacy in 1979 prior to undertaking a Ph.D in microbiology (1984). In 1996 he was appointed to the Directorship of the Institute of Infection, Immunity and Inflammation until 2008 when he became Head of the School of Molecular Medical Sciences, University of Nottingham. His research interests focus primarily on the regulation of gene expression through cell-cell communication (quorum sensing) in pathogenic bacteria and the development of novel anti-infective agents and bacterial attachment resistant polymers. He has published some 280 research papers, reviews and book chapters and patents. For his quorum sensing research he was awarded the Royal Pharmaceutical Society of Great Britain Conference Science Medal (1992), Pfizer prize in Pharmaceutical Sciences (1994) and the Society for General Microbiology Colworth Prize Lecture in 2007. Prof. Williams has served on the editorial/advisory boards of Environmental Microbiology, Journal of Bacteriology Microbiology, FEMS Microbiology Letters, Biofilms, International Journal of Medical Microbiology and Molecular Microbiology. He has also been a member of the Biotechnology and Biological Sciences Research Council U.K. (Plants and Microbes Committee), the Medical Research Council U.K. Advisory Board, the Medical Research Council U.K. College of Experts, the Infection Group of the Society for General Microbiology and was a specialist advisor for the UK RAE2008 research selectivity exercise.